Pahrtx
3 known investors
PAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
Investors · 3
Frequently asked questions
- What does Pahrtx do?
- PAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
- Who are Pahrtx's investors?
- Pahrtx's investors include AN Venture Partners, RA Capital, UTEC.